RECOVER Study on Long COVID: Virtual Town Hall Recap
ISB hosted a virtual event to share updates on the ongoing RECOVER study, a national NIH-funded initiative to understand and address Long COVID.
Back to Previous Page
Posts
Filter
-
- All Categories
- Autoimmune Diseases
- Awards
- Cancer
- Chronic Illness
- COVID and Long COVID
- Education
- Events
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Heath Lab
- Hood Lab
- Infectious Disease
- ISB-Town Hall
- Logan Center for Education
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Systemic Change
- Understanding Tumors
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
2024 Year in Review
Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.
Common Immune Response Protective Across Many Diseases
Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.
Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses
In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.
2023 Year in Review
Throughout 2023, ISB research has been published in impactful peer-reviewed journals and our scientists have been featured in major media outlets and popular podcasts. In this 2023 Year in Review, we showcase some of our most important and interesting highlights of the year.
How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells
In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.